FeesSafety
Pluang+

Jefferies-linked fund intensifies legal action against Radiant World in Singapore amid trade finance dispute

Market News
07 Sep 2026
Blockonomi
View Source
Neutral
Jefferies-linked fund intensifies legal action against Radiant World in Singapore amid trade finance dispute

Jefferies Financial Group's stock rose as a fund linked to it escalated legal efforts against iron ore trader Radiant World, seeking a freezing injunction in Singapore. The case, involving Radiant World and related entities, follows a UK court's worldwide freezing order amid disputes over trade finance invoices. Radiant World faces legal and financial challenges including frozen bank accounts and lawsuits in multiple jurisdictions, with allegations of invalid invoices. The Singapore High Court will hear the injunction request on September 9, adding to ongoing scrutiny and enforcement actions.

More News

Trump administration launches new fraud-reporting commission program and reports progress on missing children and crime reduction.

Trump administration launches new fraud-reporting commission program and reports progress on missing children and crime reduction.

In Week 92 of President Trump's second term, the administration introduced a 1% commission program rewarding Americans for reporting government fraud. They have located many missing unaccompanied alien children from previous years and reported signif...

Market News
Neutral
3 hours ago
Solana staking rewards near 5% annually after fees, based on late-October snapshot data.

Solana staking rewards near 5% annually after fees, based on late-October snapshot data.

A snapshot from October 24 shows Solana (SOL) staking offers an implied annualized reward rate of about 5% after accounting for a typical 5% validator fee. Approximately 68.7% of the total SOL supply is staked, with a 3.59% inflation rate driving the...

Protocol Fundamentals
Neutral
4 hours ago
Protagonist Therapeutics shifts to royalty model with FDA approvals and $300M buyback plan

Protagonist Therapeutics shifts to royalty model with FDA approvals and $300M buyback plan

Protagonist Therapeutics has transformed into a royalty-driven company with two FDA-approved drugs and strong cash reserves. The company secured lucrative royalties and milestones from partners Takeda and J&J, reducing its operational risks while mai...

Market News
Bullish
4 hours ago
Kaspa's block subsidy will drop about 5.6% on Nov 4, 2026, reducing miner rewards per block.

Kaspa's block subsidy will drop about 5.6% on Nov 4, 2026, reducing miner rewards per block.

Kaspa (KAS) is set to reduce its block subsidy by approximately 5.6% on November 4, 2026, lowering the base reward from about 2.06 KAS to 1.94 KAS per block. This change is part of a scheduled monthly reduction tied to the network's difficulty score,...

Protocol Fundamentals
Neutral
4 hours ago
Solana staking yields about 4.96% annually after validator fees, with 68.7% of SOL staked and rewards paid every 25 hours.

Solana staking yields about 4.96% annually after validator fees, with 68.7% of SOL staked and rewards paid every 25 hours.

Solana's staking currently offers an annual yield of approximately 4.96% after a median validator commission of 5%, based on the network's issuance rate of 3.59% and 68.7% of all SOL tokens staked. Validators earn rewards proportional to the stake de...

Protocol Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App